ThiocoralineAlternative Names: PM 93135; THIO
Latest Information Update: 21 Jul 2009
At a glance
- Originator PharmaMar
- Class Cyclic peptides; Cytostatic antibiotics
- Mechanism of Action RNA synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 21 Jul 2009 Preclinical development is ongoing in USA and Spain
- 05 Aug 2005 This compound is still in active development - (BIO-2005)
- 15 Sep 2004 This programme is still in active development